Our data demonstrated that HSDL2 is overexpressed in melanoma tissues and that its silencing blocks melanoma progression by inhibiting cell proliferation and enhancing apoptosis via inhibition of the ERK and AKT pathways. Here, HSDL2 is linked to melanoma.